You searched for "complications"

2870 results found

Embrace the blue wave of ENT!

Introducing MEDENCY, an Italian company in advanced medical technology.

In this issue...Inner Ear Therapeutics

Emma Stapleton, MBChB, FRCS (ORL-HNS), Consultant Otolaryngologist, Cochlear Implant and Skull Base Surgeon, Manchester Royal Infirmary, UK. E: emmastapleton@doctors.org.ukTwitter: @otolaryngolofox Ralph Holme, Director of Research and Insight, RNID, UK. Ralph. E: Holme@rnid.org.uk W: www.rnid.org.uk For Mar/Apr 2022, we sang the...

Internet-based cognitive behavioural therapy for adults with tinnitus

Tinnitus remains one of the most prevalent and distressing audiological symptoms. Although specialist tinnitus services are in high demand, geographical and service constraints result in limited access to these services. Internet-based cognitive behavioural therapy (ICBT) has been developed to provide...

Prudent audiology

Introduction In January 2014, Professor Mark Drakeford, Minister for Health and Social Services, defined Prudent Healthcare as, “Healthcare that fits the needs and circumstances of patients and actively avoids wasteful care that is not to the patient’s benefit.” ‘Prudent’ healthcare...

ENT OSCEs: A guide to your first ENT job and passing the MRCS (ENT) OSCE – Third Edition

ENT OSCEs has, in recent years, become one of the most widely used resources for trainees preparing for the MRCS (ENT) OSCE. Although the examination has now been phased out, the book remains highly relevant for the everyday clinical responsibilities...

Canine hearing testing and the role of otoacoustic emission tests

Otoacoustic emissions testing is an accepted method of hearing testing in humans, but have you ever considered the situation in dogs? This article discusses deafness and hearing testing in dogs and the current role of OAE testing in this species....

4th Annual Inner Ear Disorders Therapeutics Summit

Terrri Gaskell, Chief Technology Officer, Rinri TherapueticsHeld in Boston, USA, this was an essential gathering that captured the growing excitement in both the biotech and clinical communities surrounding the rapid advancements in hearing loss therapies. With the potential to significantly...

What are the risk factors for new onset tinnitus?

Factors associated with tinnitus have mainly been studied cross-sectionally. Tinnitus is associated with hearing loss, noise exposure, ototoxic medication, head and neck trauma, smoking and depression and anxiety. Only a few studies exist that report on risk factors for developing...

Patient initiated follow-up in head and neck cancer

Is it time for a change in the way we follow up head and neck cancer patients after treatment? Paul Nankivell and Hisham Mehanna explain the rationale for the PETNECK2 trial. After completion of curative intent treatment, clinical follow-up currently...

Nottingham hearing experts launch CHEAR (COVID and hearing) study

Researchers based in Nottingham are launching an in-depth and ongoing study into the possible effects of COVID-19 on patients’ hearing, tinnitus and balance. The CHEAR (COVID and hearing, otherwise known as ‘Measuring Hearing, Tinnitus and Balance following COVID-19’) Study will...

ENT UK Head & Neck Meeting

The ENT UK Head and Neck Evidence-Based Management Meeting focusing on malignancy of the nose and paranasal sinuses was held in the historic market town of York. The multidisciplinary approach required to manage this complex disease was reflected in the speaker lineup, with national representation from ENT, maxillofacial and plastic surgery, oncology, palliative medicine, histopathology and radiology.

The central ENT decontamination model: a help or a hindrance?

According to NHS England, over 400,000 patients were waiting for ENT treatment in the UK in January 2022. This figure forms part of the overall 33.5% increase in the number of patients waiting for Referral to Treatment (RTT) compared to February 2020[1].